US Stock and Financial News
Pfizer Is Reportedly In ‘Advanced Talks’ To Buy Global Blood Therapeutics For $5 Billion
Rumors that Pfizer is in “advanced talks” to acquire Global Blood Therapeutics for about $5 billion sent GBT stock flying Friday.